143 related articles for article (PubMed ID: 29393469)
1. TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
Li F; Wang Z; Lu G
Oncol Rep; 2018 Apr; 39(4):1860-1866. PubMed ID: 29393469
[TBL] [Abstract][Full Text] [Related]
2. TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.
Liu L; Xiao L; Liang X; Chen L; Cheng L; Zhang L; Wu X; Xu Q; Ma C
Oncol Rep; 2017 Jun; 37(6):3597-3605. PubMed ID: 28498400
[TBL] [Abstract][Full Text] [Related]
3. Tripartite motif containing 28 (TRIM28) promotes the growth and migration of endometrial carcinoma cells by regulating the AKT/mTOR signaling pathway.
Chen Y; Cheng H; Long H
Gen Physiol Biophys; 2021 May; 40(3):245-252. PubMed ID: 34100380
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of TRIM28 inhibits growth and increases apoptosis of nude mice with non‑small cell lung cancer xenografts.
Liu L; Zhang L; Wang J; Zhao X; Xu Q; Lu Y; Zuo Y; Chen L; Du J; Lian Y; Zhang Q
Mol Med Rep; 2018 Jan; 17(1):835-842. PubMed ID: 29115614
[TBL] [Abstract][Full Text] [Related]
5. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
[TBL] [Abstract][Full Text] [Related]
7. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
[TBL] [Abstract][Full Text] [Related]
8. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
Bai X; Ma Y; Zhang G
Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
Song X; Guo C; Zheng Y; Wang Y; Jin Z; Yin Y
BMC Cancer; 2018 Oct; 18(1):971. PubMed ID: 30309319
[TBL] [Abstract][Full Text] [Related]
12. Silencing
Li J; Zhang J; Jin L; Deng H; Wu J
Anticancer Res; 2018 Jun; 38(6):3427-3434. PubMed ID: 29848693
[TBL] [Abstract][Full Text] [Related]
13. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
Li Y; Cui N; Zheng PS; Yang WT
Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways.
Dong P; Hao F; Dai S; Tian L
J Recept Signal Transduct Res; 2018 Feb; 38(1):83-88. PubMed ID: 29369007
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
17. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
18. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z
Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169
[TBL] [Abstract][Full Text] [Related]
20. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.
Feng T; Zheng L; Liu F; Xu X; Mao S; Wang X; Liu J; Lu Y; Zhao W; Yu X; Tang W
Oncotarget; 2016 Sep; 7(36):58381-58395. PubMed ID: 27517315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
